Business
Pfizer’s COVID-19 vaccine found to be highly effective for adolescents – ABC News
A study of the Pfizer vaccine shows the jab is highly effective in adolescents aged 12-15 years old, recording higher levels of antibodies than in young adults.
Pfizer and BioNTech’s COVID-19 vaccine is safe, effective and produces robust antibody responses in 12- to 15-year olds, according to a trial run by the companies.
Key points:
- No cases were detected in the trial group who got the vaccine, compared with 18 in the placebo group
- The trial participants experienced the same side-effects that had been noted in adults
- Pfizer hopes to begin vaccinating US teenagers before the new school year
The data from a clinical trial, which puts the shot ahead of other…
Continue Reading
-
Noosa News22 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News16 hours agoHelp to make recycling stick
-
Noosa News14 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business16 hours agoAlphabet’s stock looks like a brilliant buy right now